Documents

Discussions Technicals Forecast Seasonals

BioLineRX Ltd. documents

Explore the latest documents from BioLineRX Ltd., including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.

Data partner

Description

Reported date

Form

2025

Q2 2025

Aug 14, 2025

Transcript

Earnings release8-K

Q1 2025

May 27, 2025

Transcript

Earnings release8-K

2024

Q4 2024

Mar 31, 2025

Transcript

Annual report20-F

Earnings release6-K

Q3 2024

Nov 25, 2024

Earnings release8-K

Q2 2024

Aug 15, 2024

Earnings release8-K

Q1 2024

May 28, 2024

Earnings release8-K

2023

Q4 2023

Mar 26, 2024

Annual report20-F

Earnings release8-K

Q3 2023

Nov 20, 2023

Earnings release8-K

FDA Announcement

Sep 12, 2023

Press release

Q2 2023

Aug 30, 2023

Earnings release8-K

Q1 2023

May 24, 2023

Earnings release8-K

2022

Q4 2022

Mar 22, 2023

Annual report20-F

Earnings release8-K

Q3 2022

Nov 15, 2022

Earnings release8-K

Status Update

Sep 28, 2022

Press release

Q2 2022

Aug 16, 2022

Earnings release8-K

Q1 2022

May 11, 2022

Earnings release8-K

2021

Q4 2021

Mar 16, 2022

Annual report20-F

Earnings release8-K

Q3 2021

Nov 18, 2021

Earnings release8-K

Q2 2021

Aug 18, 2021

Earnings release8-K

Q1 2021

May 26, 2021

Earnings release8-K

2020

Q4 2020

Feb 23, 2021

Annual report10-K

2019

Q4 2019

Mar 12, 2020

Annual report10-K

2018

Q4 2018

Mar 28, 2019

Annual report10-K

2017

Q4 2017

Mar 06, 2018

Annual report10-K

2016

Q4 2016

Mar 23, 2017

Annual report10-K

2015

Q4 2015

Mar 10, 2016

Annual report10-K